SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

AST Spacemobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an extensive IP and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobile shares are facing significant downward pressure following an orbital insertion failure during a Blue Origin launch that resulted in the loss of a satellite. While the community is actively debating the reliability of launch partners and the impact on the companys ambitious deployment roadmap, long-term investors are focused on insurance coverage and existing manufacturing pipelines as key catalysts for a potential rebound.

Newcourt Acquisition Corp. is a blank check company, which engages in the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded on February 25, 2021 and is headquartered in Oakland, CA.

Psyence Biomedical Ltd.

Psyence Biomedical is generating intense market attention as traders bet on a short squeeze and potential industry-wide transformation following an executive order from the U.S. government regarding the expedited research and development of psychedelic therapies. The community is heavily focused on the stock's low float, aggressive institutional interest, and the belief that the company's GMP-compliant ibogaine supply chain positions it as a critical player in a rapidly expanding mental health sector.

USA Rare Earth, Inc. is domestic supplier of rare earth magnets and heavy rare earth elements. It is developing a vertically integrated, domestic supply chain for rare earth element magnet production, with a facility in Stillwater, Oklahoma, and mining rights to the Round Top heavy rare earth and critical minerals deposit in West Texas. The company was founded in May 2019 and is headquartered in Stillwater, OK.

USA Rare Earth Inc. - Ordinary Shares - Class A

USA Rare Earth Inc

USA Rare Earth is trending following a massive $2.8 billion acquisition of Serra Verde Group, a move the market views as a strategic play to become a dominant, non-Asian leader in the rare earth supply chain. While investors are debating the impacts of the associated share dilution, community sentiment is largely focused on the company's long-term potential to anchor the Western EV and defense infrastructure.

Adobe, Inc. is a global technology company, which engages in the provision of digital marketing and media solutions. It operates through the following segments: Digital Media, Digital Experience, and Publishing and Advertising. The Digital Media segment offers products and services that enable individuals, teams, businesses, and enterprises to create, publish, and promote content anywhere and accelerate productivity by transforming view, share, engage with and collaborate on documents and creative content. The Digital Experience segment focuses on integrated platform and set of products, services, and solutions that enable businesses to create, manage, execute, measure, monetize, and optimize customer experiences that span from analytics to commerce. The Publishing and Advertising segment includes legacy products and services that address diverse market opportunities, including eLearning solutions, technical document publishing, web conferencing, document and forms platform, web app development, high-end printing, and Adobe Advertising offerings. The company was founded by Charles M. Geschke and John E. Warnock in December 1982 and is headquartered in San Jose, CA.

Adobe Inc

Adobe is facing intense market volatility as investors weigh the potential of its AI-driven enterprise tools against fears that generative AI could disrupt its established creative software moat. The stock is currently experiencing significant downward pressure as the community debates whether the recent sell-off represents an irrational disconnect from elite fundamentals or a structural shift in the software landscape.

Cleveland-Cliffs, Inc. is a flat-rolled steel company, which engages in provision of iron ore pellets to the North American steel industry. It focuses on the production of metallic and coke, iron making, steelmaking, rolling and finishing, and downstream tubular components, stamping, and tooling. It operates through the Steelmaking and Other Businesses segments. The company was founded in 1847 and is headquartered in Cleveland, OH.

Cleveland-Cliffs Inc

Cleveland-Cliffs is currently a focal point for investors as the community debates the impact of potential trade enforcement, ongoing industry consolidation rumors, and the CEO's recent strategic maneuvers. While some market participants are optimistic about the company's vertically integrated position and the long-term potential for a POSCO partnership, others are expressing significant caution regarding the company's debt levels and recent insider selling activity.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

Sellas Life Sciences is gaining momentum as retail investors and the community ramp up activity ahead of the upcoming AACR conference, where new data for the SLS009 platform will be presented. Supporters are actively discussing the potential for a significant price movement driven by heavy call option positioning and large-scale short interest, while long-term investors remain focused on the clinical potential of the GPS pivotal Phase 3 study.

Nektar Therapeutics is a biotechnology company, which engages in the discovery and development of novel therapies which selectively modulate the immune system to treat autoimmune disorders. It also focuses on immunology and unparalleled expertise in polymer chemistry to create one-of-a-kind, highly-selective medicines with optimal therapeutic benefit. The company was founded in 1990 and is headquartered in San Francisco, CA.

Nektar Therapeutics

Nektar Therapeutics is gaining significant market attention as traders position for imminent Phase 2b data from its alopecia areata trial, a catalyst that follows a period of positive momentum in its broader autoimmune pipeline. While some community members voice concerns over potential volatility and past management execution, the bullish sentiment remains anchored in the drug's differentiated mechanism of action and the anticipation of a potential settlement or partnership deal involving Eli Lilly.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Candel Therapeutics is experiencing significant momentum and investor interest as the community points to strong clinical trial data, the upcoming BLA submission, and a highly undervalued market cap relative to its pipeline potential. Investors are actively discussing the possibility of a buyout or strategic partnership, with many viewing current price levels as an accumulation opportunity ahead of key data catalysts.

Compass Pathways Plc is a biotechnology company, which provides mental health care services. It focuses on improving the lives of those who are suffering with mental health challenges and who are not helped by current treatments. The company was founded by Goldsmith George Jay and Malievskaia Ekaterina in 2016 and is headquartered in London, the United Kingdom.

Compass Pathways Plc - ADR

COMPASS Pathways

COMPASS Pathways (CMPS) and peers in the psychedelic biotech space are surging following an executive order from President Trump designed to accelerate research and FDA review pathways for mental health treatments. While the sector is experiencing high-conviction momentum and institutional interest, community discourse remains divided between those betting on long-term clinical success and those wary of volatility and the potential for short-term speculative 'pump and dump' dynamics.

Cybin, Inc. operates as a clinical-stage biopharmaceutical company on a mission to create safe and effective psychedelic-based therapeutics to address the large unmet need for new and innovative treatment options for people who suffer from mental health conditions. It is currently developing CYB003, a proprietary deuterated psilocybin analog for the treatment of major depressive disorder and CYB004, a proprietary deuterated DMT molecule for generalized anxiety disorder and has a research pipeline of investigational psychedelic-based compounds. The company was founded by Paul Glavine, Eric So, and John Kanakis on October 13, 2016 and is headquartered in Toronto, Canada.

Helus Pharma Inc.

Helus Pharma is trending as investors react to a recent corporate rebranding and executive shifts while monitoring clinical progress for its MDD and GAD treatment pipeline. Community sentiment is polarized, with some traders optimistic about the potential for regulatory tailwinds and upcoming trial data, while others remain skeptical due to the company's history of dilution and previous share price performance.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Arch Capital Group Ltd. $ACGL Shares Acquired by Asset Management One Co. Ltd.

Asset Management One Co. Ltd. raised its holdings in shares of Arch Capital Group Ltd. (NASDAQ:ACGL - Free Report) by 10.6% in the fourth quarter, according to the company in its most recent filing...

CINF Stock Trades at 1.60x Book Value: Should Investors Hold?

Cincinnati Financial stock gains from its agency-centric model, strong cash flows, commercial lines expansion, higher interest income and disciplined capital deployment.

W.R. Berkley Gears Up to Report Q1 Earnings: What's in the Cards?

WRB's first-quarter results are likely to reflect solid premium growth across both segments, higher income from fixed-maturity securities and improved pricing.

KBC Group NV Has $30.41 Million Stake in Arch Capital Group Ltd. $ACGL

KBC Group NV lowered its position in Arch Capital Group Ltd. (NASDAQ:ACGL - Free Report) by 24.8% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange...

Arch Capital Group Ltd. $ACGL Shares Purchased by Cwm LLC

Cwm LLC boosted its stake in Arch Capital Group Ltd. (NASDAQ:ACGL - Free Report) by 4.1% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange...

Arch Capital Group Ltd. $ACGL Shares Sold by SeaBridge Investment Advisors LLC

SeaBridge Investment Advisors LLC lowered its holdings in Arch Capital Group Ltd. (NASDAQ:ACGL - Free Report) by 77.3% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 4,998 shares of the insurance prov...

Arch Capital Group Ltd. $ACGL Shares Acquired by Sumitomo Mitsui Trust Group Inc.

Sumitomo Mitsui Trust Group Inc. lifted its position in shares of Arch Capital Group Ltd. (NASDAQ:ACGL - Free Report) by 3.4% during the fourth quarter, according to the company in its most recent...

Is a Beat in Store for Progressive This Earnings Season?

PGR's first-quarter revenues are expected to increase 9.7% to $22.6 billion, and EPS is likely to be $4.77 on auto policy and investment income growth.

Travelers Gears Up to Report Q1 Earnings: What's in the Cards?

TRV's Q1 results are likely to reflect higher premiums, aided by strong retention, stronger investment income and improved underwriting.

Arch Capital Group Ltd. $ACGL Stock Position Increased by High Ground Investment Management LLP

High Ground Investment Management LLP raised its position in shares of Arch Capital Group Ltd. (NASDAQ:ACGL - Free Report) by 5.7% during the 4th quarter, according to its most recent 13F filing with...

Arch Capital Group Ltd. engages in the provision of property and casualty insurance and reinsurance lines. It operates through the following segments: Insurance, Reinsurance, Mortgage, Corporate, and Other. The Insurance segment consists of insurance underwriting units which offer specialty product lines like construction and national accounts, excess and surplus casualty, lenders products, professional lines, and programs. The Reinsurance segment is composed of reinsurance underwriting which offers specialty product lines such as casualty, marine and aviation, other specialty, property catastrophe, property excluding property catastrophe, and other. The Mortgage segment includes U.S. and international mortgage insurance and reinsurance operations as well as GSE credit risk sharing transactions. The Corporate segment represents net investment income, other income, corporate expense, interest expense, net realized gains and losses, and net impairment losses. The Other segment refers to Watford Re. which is a variable interest entity. The company was founded by Clements Robert in March 1995 and is headquartered in Hamilton, Bermuda.

Fiscal Period	Estimated	Reported	Surprise	Result
Q1 '26	$2.48	--	--	N/A
Q4 '25	$2.59	$2.98	14.87%	BEAT
Q3 '25	$2.26	$2.77	22.76%	BEAT
Q2 '25	$2.30	$2.58	12.10%	BEAT
Q1 '25	$1.32	$1.54	16.48%	BEAT

ACGL
Arch Capital Group Ltd

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q1 '26

Historical Earnings

Latest ACGL News

ACGLArch Capital Group Ltd